Series A startups in Shanghai, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| MaxSense Technology | Shanghai | Series A | $14.9M | 2026-09-29 |
| SynMetaBio | Shanghai | Series A | $14.7M | 2026-07-06 |
| Degron Therapeutics | Shanghai | Series A | $40.0M | 2026-05-14 |
| Allink Biotherapeutics | Shanghai | Series A | $47.0M | 2025-12-16 |
| Brise Pharma | Shanghai | Series A | $28.1M | 2025-11-11 |
| OnerWay | Shanghai | Series A | $10.0M | 2025-08-11 |
| Super Rui Technology | Shanghai | Series A | $13.7M | 2025-02-11 |
| Dream Island | Shanghai | Series A | $10.0M | 2025-01-08 |
8 rows of the CSV in 5 of its 18 columns.
- The 738 series a startups in Shanghai, China have raised $6.1B in total.
- 87 of them closed their most recent round in the last 12 months, $1.7B combined.
- The largest of those rounds is Anew Labs' $290.0M Series A, dated September 2026.
- The most recent is Hydrogen Phoenix Technology's $15.0M Series A on 23 October 2026.
- IDG Capital is an investor in 8 of them, more than any other fund.
- Software is the most common sector, with 210 companies (28%).
- 20% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (44% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 738| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| MaxSense Technology | MaxSense Technology develops autonomous driving systems and industrial operation optimization software. | Software | Series A | $14.9M | 2026-09-29 | $15.3M | Leading Capital, Yijin Capital, Galaxy Capital | 11 to 50 | 2015 |
| SynMetaBio | SynMetaBio develops synthetic biological materials by combining synthetic biology with material design. | Biotech | Series A | $14.7M | 2026-07-06 | $16.1M | MiraclePlus, Linear Capital, Danen Capital | 11 to 50 | 2021 |
| Degron Therapeutics | Degron Therapeutics discovers molecular glue degraders for cancer treatment. | Biotech | Series A | $40.0M | 2026-05-14 | $94.0M | Baidu Ventures, BioVenture, New Alliance Capital +2 | 101 to 250 | 2021 |
| Allink Biotherapeutics | Allink Biotherapeutics develops multi-specific antibodies for treating cancer and immune disorders. | Biotech | Series A | $47.0M | 2025-12-16 | $89.0M | Legend Capital, Gaorong Capital, BioVenture +2 | 11 to 50 | 2023 |
| Brise Pharma | Brise Pharma provides scientific research and technical services in the pharmaceutical field. | Biotech | Series A | $28.1M | 2025-11-11 | $228.3M | Qiming Venture Partners, Sherpa Healthcare Partners, BioTrack Capital +1 | 11 to 50 | 2021 |
Table 1. Series A startups in Shanghai, China: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 738.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Allink Biotherapeutics | Allink Biotherapeutics develops multi-specific antibodies for treating cancer and immune disorders. | Biotech | Series A | $47.0M | 2025-12-16 | $89.0M | Legend Capital, Gaorong Capital, BioVenture +2 | 11 to 50 | 2023 |
| 2 | Degron Therapeutics | Degron Therapeutics discovers molecular glue degraders for cancer treatment. | Biotech | Series A | $40.0M | 2026-05-14 | $94.0M | Baidu Ventures, BioVenture, New Alliance Capital +2 | 101 to 250 | 2021 |
| 3 | MaxSense Technology | MaxSense Technology develops autonomous driving systems and industrial operation optimization software. | Software | Series A | $14.9M | 2026-09-29 | $15.3M | Leading Capital, Yijin Capital, Galaxy Capital | 11 to 50 | 2015 |
| 4 | SynMetaBio | SynMetaBio develops synthetic biological materials by combining synthetic biology with material design. | Biotech | Series A | $14.7M | 2026-07-06 | $16.1M | MiraclePlus, Linear Capital, Danen Capital | 11 to 50 | 2021 |
Table 2. Series A startups in Shanghai, China: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | IDG Capital | Private equity firm | Beijing, China | 8 | 1% | ||
| 2 | Gaorong Capital | Venture capital firm | Wangjing, China | 7 | 1% | 1 | Allink Biotherapeutics |
| 3 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 7 | 1% | ||
| 4 | GSR Ventures | Venture capital firm | Menlo Park, United States | 6 | 1% | ||
| 5 | ZhenFund | Entrepreneurship program | Beijing, China | 6 | 1% | ||
| 6 | Matrix Partners China | Venture capital firm | Beijing, China | 6 | 1% | ||
| 7 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 4 | 1% | ||
| 8 | Cowin Capital | Private equity firm | Shenzhen, China | 4 | 1% | ||
| 9 | Qingsong Fund | Venture capital firm | Shenzhen, China | 4 | 1% | ||
| 10 | GGV Capital | Venture capital firm | Menlo Park, United States | 4 | 1% | ||
| 11 | Meridian Capital Asia | Private equity firm | Singapore | 4 | 1% | ||
| 12 | SAIF Partners | Private equity firm | Hong Kong | 4 | 1% | ||
| 13 | Sinovation Ventures | Venture capital firm | Beijing, China | 4 | 1% | ||
| 14 | SIG China (SIG Asia Investments) | Private equity firm | Huangpu, China | 4 | 1% | ||
| 15 | Sequoia Capital | Venture capital firm | Menlo Park, United States | 4 | 1% |
Table 3. Series A startups in Shanghai, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 210 | 28% | $1.7B |
| Health care | 149 | 20% | $3.3B |
| Hardware | 118 | 16% | $1.6B |
| Biotech | 76 | 10% | $2.1B |
| Commerce | 75 | 10% | $67.1M |
| Fintech | 66 | 9% | $1.2B |
| Artificial intelligence | 59 | 8% | $635.7M |
| Education | 30 | 4% | $64.8M |
| Energy | 21 | 3% | $25.1M |
| Cybersecurity | 9 | 1% | $1.0M |
Table 4. Series A startups in Shanghai, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 738 | 100% | $5.0M |
Table 5. Series A startups in Shanghai, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 3 | 3% | |
| October 2026 | 4 | 5% | $272.9M |
| September 2026 | 7 | 8% | $470.0M |
| August 2026 | 10 | 11% | $179.1M |
| July 2026 | 8 | 9% | $163.6M |
| June 2026 | 5 | 6% | $3.0M |
| May 2026 | 9 | 10% | $117.2M |
| April 2026 | 3 | 3% | $183.3M |
| March 2026 | 8 | 9% | $11.6M |
| February 2026 | 4 | 5% | $86.6M |
| January 2026 | 10 | 11% | $24.4M |
| December 2025 | 14 | 16% | $194.2M |
| November 2025 | 2 | 2% |
Table 6. Series A startups in Shanghai, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 71 | 10% | $1.5B |
| 2025 | 70 | 9% | $880.9M |
| 2024 | 29 | 4% | $229.0M |
| 2023 | 42 | 6% | $350.0M |
| 2022 | 46 | 6% | $341.0M |
| 2021 | 51 | 7% | $313.9M |
Table 7. Series A startups in Shanghai, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 40 | 6% |
| 2020 to 2022 | 103 | 14% |
| 2015 to 2019 | 278 | 38% |
| 2010 to 2014 | 211 | 29% |
| Before 2010 | 94 | 13% |
Table 8. Series A startups in Shanghai, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 81 | 13% |
| 11 to 50 | 268 | 44% |
| 51 to 100 | 112 | 18% |
| 101 to 250 | 80 | 13% |
| 251 to 500 | 34 | 6% |
| 501 to 1,000 | 24 | 4% |
| 1,001 to 5,000 | 11 | 2% |
| 5,001 to 10,000 | 1 | 0% |
| 10,001 or more | 2 | 0% |
Table 9. Series A startups in Shanghai, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series A and its headquarters is in Shanghai, China. On 16 November 2026 that is 738 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 738 rows: 278 have no round amount, 0 no city and 523 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series a startups in Shanghai, China are on the list?
- 738, in the file dated 16 November 2026. 87 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 738 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.